Table 1.

Demographic and clinical data for antibody positive cases

Patient	Antibody, titre	Sex	Age	Illness duration at intake/assay (days)	Positive psychotic symptoms	Negative psychotic symptoms	Cognitive deficits	Time to recovery, time to relapse, (months)	Total follow up (months)
1.	NMDAR score 2	M	21	4	Grandiose and paranoid delusions, delusions of control	Anergia, poor motivation	Verbal fluency	6, n/a	36
2.	NMDAR score 1	M	28	730	Auditory verbal hallucinations. Paranoid delusions, delusions of control	No	No	Chronic	36
3.	VGKC 1435 pM	F	22	14	Paranoid delusions, thought disorder	Poor self care and motivation, anergia	Working memory	6, 12	12
4.	NMDAR score 1.5	M	19	88	Auditory verbal hallucinations, thought disorder, paranoid grandiose delusions	Poor motivation, social withdrawal, incongruent affect	Recall and verbal fluency	5 (partial), n/a	7
Antibody negative Cameo cases n = 43	n/a	M:F 4:1	22 (17–35)	145 (2–270)	Auditory hallucinations, paranoid grandiose delusions	Social withdrawal	Not known	Chronic 23%	36
								Relapse 58%
								No relapse 19%